Eligibility Criteria

If your evidence-based cancer control program meets all of the inclusion criteria listed below, please visit the on-line program registration form to submit the information regarding your program for further consideration for the EBCCP website.

Program Eligibility Criteria:

Outcome finding(s) must be published in a peer-reviewed journal.
The study must have produced one or more positive behavioral and/or psychosocial outcomes (p≤.05) among individuals, communities, or populations.
Evidence of outcomes must be demonstrated in at least one study, using an experimental or quasi-experimental design; Experimental designs require random assignment, a control or comparison group, and pre- and post- assessments. Quasi-experimental designs do not require random assignment but do require a comparison or control group and pre- and post- assessments. Studies that are based on single-group, pre-/post-test designs do not meet this requirement.
The program must have messages, materials, and/or other components that include English and can be disseminated in a U.S. community or clinical setting.
The program must have been evaluated within the last 10 years.

If your program does not meet these criteria but you would like to find out how it might, please contact us for more information.

EBCCP Program Areas	Example Primary Study Outcomes*^‡
*Eligible outcomes may be collected via self-report or observation, and whenever possible, use of biologic samples (e.g., blood or urine) or healthcare administrative data (e.g., chart review, EHR data pulls) are encouraged. ^‡ Use of validated measures for study outcomes is strongly encouraged. Examples of validated data collection tools: PhenX Toolkit (with alcohol, tobacco, and other measures), Dietary Assessment Research Resources, Physical Activity Assessment Resources, and Group-Evaluated Measures.
Alcohol Use	Prevention of alcohol use initiation – Follow-up at 12 months minimum Increase alcohol abstinence (e.g., percentage of days abstinent, duration of abstinence) – Follow-up at 3 months minimum Reduction in alcohol consumption quantity, frequency, or intensity (e.g., drinks per drinking day, drinks per day, percentage of heavy drinking days) – Follow-up at 3 months minimum
Cancer Screening: Breast, Cervical, Colorectal	Improvements in guideline-concordant screening uptake and/or adherence or other behavioral outcomes (e.g., scheduling an appointment)
Cancer Screening: Lung	Improvements in guideline-concordant screening uptake and/or adherence Improvements in other behavioral and/or psychosocial outcomes (e.g., preference or values alignment, improved communication, decisional satisfaction or conflict, scheduling an appointment) Improvements in cognitive outcomes (e.g., knowledge, awareness, risk perception)
Cancer Screening: Prostate	Improvements in behavioral and/or psychosocial outcomes (e.g., preference or values alignment, improved communication, decisional satisfaction or conflict, opting for or against a given clinical service) Improvements in cognitive outcomes (e.g., knowledge, awareness, risk perception)
Cancer Screening: Follow-up to Abnormal Screening Results	Improvements in adherence to appropriate follow-up evaluation and/or testing (e.g., biopsy, colonoscopy after abnormal stool test, cytology or colposcopy after positive HPV test or abnormal Pap) and timeliness of follow-up
Cancer Survivorship	Increase in survival time, health-related quality of life; decrease in pain or suffering Improvements in behavioral and/or psychosocial outcomes (e.g., anxiety, depression, stress, mood, self-efficacy, use of coping techniques, improved communication, decreased uncertainty) Improvements in cognitive outcomes (e.g., mental functioning, memory, knowledge, risk perception)
Diet & Nutrition	Improvements in dietary and nutritional intake (e.g., fruit and vegetable consumption, reductions in calories from total fats and saturated fats, consumption of sugar-sweetened beverages)
Genetic & Genomic Testing	Improvements in behavioral and/or psychosocial outcomes (e.g., decisional satisfaction or conflict, opting for recommended genetic services, notification of family members for cascade testing) Improvements in cognitive outcomes (e.g., knowledge, awareness, risk perception)
HPV Vaccination	Improvements in HPV vaccine initiation and/or series completion Improvements in provider communication with parents and/or patients
Obesity Management	Improvements in anthropometric measures (e.g., weight, BMI, waist circumference)
Physical Activity	Improvements in physical activity (e.g., minutes of moderate to vigorous physical activity or exercise, reductions in sedentary behaviors)
Sun Safety & Indoor Tanning	Improvements in ultraviolet radiation safety behaviors (e.g., use of sunscreen, avoidance of indoor tanning)
Tobacco Control	Prevention of tobacco use initiation – Follow-up at 12 months minimum Increase in 7-day point-prevalence abstinence or continuous abstinence – Follow-up at 6 months minimum, biologic verification strongly encouraged Reduction in secondhand smoke exposure (e.g., decrease in ambient nicotine level, increase in indoor smoking bans)

Outcomes Matrix